Lb Pharmaceuticals LBRX
NASDAQ LBRX
$49.34 +1.82 (+3.83%)
As of: Sep 4, 2026 · 3:59 PM EDT

Lb Pharmaceuticals (LBRX) Pension (2024 - 2026)

Lb Pharmaceuticals (LBRX) posted quarterly Pension of $262000.0 for Q1 2026, down 49.13% quarter-over-quarter from $515000.0 in Q4 2025.

Analysis

Lb Pharmaceuticals (LBRX) Pension (2024 - 2026) Analysis & Trends

Lb Pharmaceuticals' Pension history runs 3 years deep, the most recent figure standing at $262000.0 for Q1 2026.

  • In Q1 2026, Pension changed N/A year-over-year to $262000.0; the TTM figure through Mar 2026 stood at $262000.0 (changed N/A YoY), while the FY2025 annual figure was $515000.0, down 35.62% from the prior year.
  • Pension for Q1 2026 stood at $262000.0, down from $515000.0 in the prior quarter.
  • The five-year high for Pension was $868000.0 in Q3 2025, with the low at $262000.0 in Q1 2026.
  • The 3-year median for Pension is $657500.0 (2024), against an average of $611250.0.
  • Peak annual rise in Pension reached 35.62% in 2025, while the deepest fall reached 35.62% in 2025.
  • Lb Pharmaceuticals' Pension stood at $800000.0 in 2024, then plunged by 35.62% to $515000.0 in 2025, then sank by 49.13% to $262000.0 in 2026.
  • Business Quant data shows LBRX's Pension at $262000.0 in Q1 2026, $515000.0 in Q4 2025, and $868000.0 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Lb Pharmaceuticals 1.49 Bn 1.49 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 798,000.00
Mar 31, 2026 262,000.00
Dec 31, 2025 515,000.00
Sep 30, 2025 868,000.00
Dec 31, 2024 800,000.00